₹ 0.4 Cr
Volume Transacted
(Dec 26, 2024)
5.1 K
Stocks Traded
(Dec 26, 2024)
Last Updated on: Dec 26, 2024
The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.
1M
1Y
3Y
5Y
Date | Price (₹) | Day Open (₹) | Day High (₹) | Day Low (₹) |
---|
26 Dec 2024 | 764.75 | 801.15 | 801.15 | 760 |
24 Dec 2024 | 765.95 | 777.35 | 784.9 | 765.1 |
23 Dec 2024 | 778 | 808.1 | 819.85 | 765.65 |
20 Dec 2024 | 814.4 | 820.25 | 844 | 800.75 |
19 Dec 2024 | 829 | 815.05 | 836.3 | 815.05 |
18 Dec 2024 | 830.55 | 800.05 | 862.5 | 800.05 |
17 Dec 2024 | 822.45 | 794.55 | 826.05 | 794.55 |
16 Dec 2024 | 810.65 | 809.05 | 832.9 | 802 |
13 Dec 2024 | 816 | 815 | 827.8 | 796.5 |
12 Dec 2024 | 819.4 | 895.6 | 895.6 | 816 |
Date | Price (₹) |
---|---|
26 Dec 2024 | 764.75 |
24 Dec 2024 | 765.95 |
23 Dec 2024 | 778 |
20 Dec 2024 | 814.4 |
19 Dec 2024 | 829 |
18 Dec 2024 | 830.55 |
17 Dec 2024 | 822.45 |
16 Dec 2024 | 810.65 |
13 Dec 2024 | 816 |
12 Dec 2024 | 819.4 |
Shilpa Medicare gets GMP certification for Hyderabad Facility
The inspection was conducted from 24 September 2024 to 26 September 2024. On conclusion of...
20 Dec 2024 15:14
Shilpa Medicare JV gets USFDA approval for IMKELDI drug
Oncosol is 50:50 joint venture between Liqmeds Lifecare, a Zydus Group company, and Koana ...
27 Nov 2024 15:47
Shilpa Medicare gets nod for Phase III clinical trials of Human Albumin
Albumin is in high demand for various medical treatments, including restoring blood volume...
26 Nov 2024 15:00
Shilpa Medicare spurts on European regulator nod for Octreotide & Nifedipine
Octreotide, a synthetic peptide manufactured by Shilpa Pharma Lifesciences through solid-p...
19 Nov 2024 11:24
Shilpa Medicare rallies after robust Q2 results
Profit before tax (PBT) surged 300.98% to Rs 36.77 crore in Q2 FY25 over Q2 FY24. EBITDA j...
14 Nov 2024 10:39
Shilpa Medicare update on its CDMO partner - Unicycive Therapeutics
Unicycive Therapeutics, Inc. (NASDAQ: UNCY) has announced that the U.S. Food and Drug Admi...
12 Nov 2024 15:02
Unlimited trading starting at just Rs. 249*